Simplex Trading’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-211,467
Closed -$6.27M 10288
2023
Q4
$6.27M Buy
211,467
+967
+0.5% +$19.3K ﹤0.01% 1388
2023
Q3
$3.34M Sell
210,500
-95,478
-31% -$1.59M ﹤0.01% 1629
2023
Q2
$5.77M Buy
305,978
+186,966
+157% +$2.21M ﹤0.01% 1220
2023
Q1
$457K Buy
119,012
+57,332
+93% +$244K ﹤0.01% 3372
2022
Q4
$305K Buy
61,680
+17,076
+38% +$92.6K ﹤0.01% 3725
2022
Q3
$213K Sell
44,604
-30,772
-41% -$162K ﹤0.01% 4530
2022
Q2
$339K Sell
75,376
-40,914
-35% -$178K ﹤0.01% 3942
2022
Q1
$553K Buy
116,290
+33,227
+40% +$184K ﹤0.01% 3724
2021
Q4
$616K Buy
83,063
+61,163
+279% +$380K ﹤0.01% 3522
2021
Q3
$144K Hold
21,900
﹤0.01% 6097
2021
Q2
$144K Buy
+21,900
New +$153K ﹤0.01% 6200
2020
Q2
Sell
-16,422
Closed -$69.8K 8579
2020
Q1
$55K Sell
16,422
-1,966
-11% -$8.6K ﹤0.01% 5039
2019
Q4
$93K Buy
18,388
+17,704
+2,588% +$60.1K ﹤0.01% 4588
2019
Q3
$1K Sell
684
-8,244
-92% -$21.9K ﹤0.01% 7102
2019
Q2
$19K Sell
8,928
-41,605
-82% -$98.4K ﹤0.01% 5656
2019
Q1
$136K Buy
50,533
+15,883
+46% +$68.8K ﹤0.01% 4016
2018
Q4
$166K Sell
34,650
-10,747
-24% -$65.2K ﹤0.01% 3350
2018
Q3
$429K Buy
45,397
+16,321
+56% +$157K ﹤0.01% 2794
2018
Q2
$282K Buy
+29,076
New +$307K ﹤0.01% 3082
2018
Q1
Sell
-27,268
Closed -$269K 7058
2017
Q4
$174K Buy
+27,268
New +$168K 0.01% 1376
2017
Q3
Sell
-23,897
Closed -$159K 6834
2017
Q2
$169K Buy
23,897
+23,425
+4,963% +$107K 0.01% 1312
2017
Q1
$1K Sell
472
-40,313
-99% -$118K ﹤0.01% 5854
2016
Q4
$83K Buy
40,785
+6,136
+18% +$12.3K 0.01% 1701
2016
Q3
$92K Buy
34,649
+23,407
+208% +$68.1K 0.01% 1586
2016
Q2
$34K Sell
11,242
-1,528
-12% -$9.58K ﹤0.01% 2420
2016
Q1
$108K Buy
12,770
+11,993
+1,544% +$101K 0.01% 1292
2015
Q4
$10K Buy
+777
New +$9.56K ﹤0.01% 3324
2015
Q2
Sell
-3,439
Closed -$37.8K 6014
2015
Q1
$30K Sell
3,439
-5,364
-61% -$38.9K ﹤0.01% 1980
2014
Q4
$54K Buy
+8,803
New +$80.5K 0.01% 1328

Other funds holding IMGN

Simplex Trading's IMGN Position: Q1 2024 in Review

Simplex Trading sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 211,467 shares — an estimated $6.27M sold.

Simplex Trading first reported a position in IMGN in Q4 2014 and held it in 29 quarters. The position peaked at $6.27M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Simplex Trading reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Simplex Trading sold 211,467 Immunogen Inc shares in Q1 2024, an estimated $6.27M.
  • Simplex Trading first reported a position in Immunogen Inc in Q4 2014 and held it in 29 quarters.
  • Simplex Trading's Immunogen Inc position peaked at $6.27M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.